“…Based on our practical synthesis of kainoid analogs, we designed a C4-heteroaryl kainoid that was expected to be more potent than its parent natural product kainic acid. 17,19,20 Our previous SAR analysis 12 suggested that C4-aryl kainoids are highly potent KAR agonists, mostly due to the C4 substituent participating in π-π stacking with a key phenol side chain within the binding pocket (Tyr448, Figure 3). Aminooxazolyl kainoid 1 was selected for two main reasons: (1) its electron-deficient quadrupole would complement and enhance π-π stacking interactions with Tyr488, and (2) the 2amino substituent would allow easy attachment of different molecular cargo to create new chemical biology tools (e.g., fluorescent tags, biotin, photoswitch, etc.…”